N-acetyltransferase expression and DNA binding of N-hydroxyheterocyclic amines in human prostate epithelium

Carcinogenesis

Volumn 20, Issue 8, 1999, Pages 1591-1595

  Wang, Ching Y ^a   Debiec Rychter, Maria ^b   Schut, Herman A J ^c   Morse, Philo ^a   Jones, Richard F ^a   Archer, Corlis ^a   King, Charles M ^d   Haas, Gabriel P ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE;

AGED; ARTICLE; CLINICAL ARTICLE; DNA ADDUCT; DNA BINDING; DNA REPAIR; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY;

ARYLAMINE N-ACETYLTRANSFERASE; CARCINOGENS; DNA; DNA ADDUCTS; EPITHELIAL CELLS; HUMANS; IMIDAZOLES; ISOENZYMES; MALE; PROSTATE; PROSTATIC HYPERPLASIA; PYRIDINES; QUINOXALINES;

EID: 0032818433     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.8.1591     Document Type: Article

References (27)

1. Giovannucci, E. (1995) Epidemiologic characteristics of prostate cancer. Cancer, 75 (suppl.), 1766-1777.
2. Wynder, E.L., Fujita, Y., Harris, R.E., Hirayama, T. and Hiyama, T. (1991) Comparative epidemiology of cancer between the United States and Japan. A second look. Cancer, 67, 746-763.
3. Felton, J.S., Malfatti, M.A., Knize, M.G., Salmon, C.P., Hopmans, E.C. and Wu, R.W. (1997) Health risks of heterocyclic amines. Mutat. Res., 376, 37-41.
4. Manabe, S., Toyama, K., Wada, O. and Aramaki, T. (1991) Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in cigarette smoke condensate. Carcinogenesis, 12, 1945-1947.
5. Rodriguez, C., Tatham, L.M., Thun, M.J., Calle, E.E. and Heath, C.W.Jr (1997) Smoking and fatal prostate cancer in a large cohort of adult men. Am. J. Epidemiol., 145, 466-475.
6. Dipple, A. (1995) DNA adducts of chemical carcinogens. Carcinogenesis, 16, 437-441.
7. Kadlubar, F.F. (1994) Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans. Drug Metab. Rev., 26, 37-46.
8. King, C.M., Land, S.J., Jones, R.F., Debiec-Rychter, M., Lee, M.-S. and Wang, C.Y. (1997) Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines. Mutat. Res., 376, 123-128.
9. Bell, D.A,. Badawi, A.F., Lang, N.P., Ilett, K.F., Kadlubar, F.F. and Hirvonen, A. (1995) Polymorphism in the N-acetyltransferase I (NAT1) polyadenylation signal: association of NAT*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res., 55, 5226-5229.
10. Risch, A., Wallace, D.M., Bathers, S. and Sim, E. (1995) Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum. Mol. Genet., 4, 231-236.
11. Chen, J., Stampfer, M.J., Hough, H.L., Gacia-Closa, M., Willett, W.C., Hennekens, C.H., Kelsey, K.T. and Hunter, D.J. (1998) A prospective study of N-acetyltransferase genotype, red meat intake and risk of colorectal cancer. Cancer Res., 58, 3307-3311.
12. Shirai, T., Sano, M., Tamano, S. et al. (1997) The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res., 57, 195-198.
13. Turteltaub, K.W., Knize, M.G., Buonarati, M.H., McManus, M.E., Veronese, M.E., Mazrimas, J.A. and Felton, J.S. (1990) Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by liver microsomes and isolated rabit cytochrome P450 isozymes. Carcinogenesis, 11, 941-946.
14. Yamazoe, Y., Abu-Zeid, M., Manabe, S., Toyama, S. and Kato, R. (1988) Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat liver microsomes and purified cytochrome P-450. Carcinogenesis, 9, 105-109.
15. Rheim, J.S., Webber, M.M., Bello, D., Lee, M.S., Arnstein, P., Chen, L.-S. and Jay, G. (1994) Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proc. Natl Acad. Sci. USA, 91, 11874-11878.
16. Wang, C.Y., Yamada, H., Morton, K.C., Zukowski, K., Lee, M.-S. and King, C.M. (1988) Induction of repair synthesis of DNA in mammary and urinary bladder epithelial cells by the N-hydroxy derivatives of carcinogenic arylamines. Cancer Res., 48, 4227-4232.
17. Schut, H.A.J. and Herzog, C.R. (1992) Formation of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in male Fischer-344 rats. Cancer Lett., 67, 117-124.
18. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx-and PhIP-treated monkeys. Carcinogenesis, 14, 1389-1395.
19. 32P-postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene. Carcinogenesis, 6, 1117-1126.
20. Debiec-Rychter, M., Land, S.J. and King, C.M. (1996) Histological localization of mRNAs for rat acetyltransferases that acetylate serotonin and genotoxic arylamines. Cancer Res., 56, 1517-1525.
21. Cotran, R.S., Kumar, V. and Robbin, S.L. (1994) Male genital system. In Cotran, R.S, Kumar, V. and Robbin, S.L. (eds) Pathologic Basis of Disease. W.B. Saunders, Philadelphia, PA, pp. 1025-1031.
22. Agundez, J.A., Martinez, C., Olivera, M., Gallardo, L., Ladero, J.M., Rosado, C., Prados, J., Rodriguez-Molina, J., Resel, L. and Benitez, J. (1998) Expression in human prostate of drug-and carcinogen-metabolizing enzymes: association with prostate cancer risk. Br. J. Cancer, 78, 1361-1367.
23. Minchin, R.F., Reeves, P.T., Teitel, C.H., McManus, M.E., Mojarrabi, B., Ilett, K.F. and Kadlubar, F.F. (1992) N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem. Biophys. Res. Commun., 185, 839-844.
24. Negishi, C., Yamaizumi, Z. and Sato, S. (1989) Nucleic acid binding and mutagenicity of active metabolites of 2-amino-3,8-dimethyl[4,5-f]quinoxaline. Mutat. Res., 210, 127-134.
25. Sugimura, T. (1997) Overview of carcinogenic heterocyclic amines. Mutat. Res., 376, 211-219.
26. Sinha, R., Rothman, N., Mark, S.D., Murray, S., Brown, E.D., Levander, O.A., Davies, D.S., Lang, N.P., Kadlubar, F.F. and Hoover, R.N. (1995) Lower levels of urinary 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) in humans with higher CYP1A2 activity, Carcinogenesis, 16, 2859-2861.
27. Stillwell, W.G., Kidd, L.C., Wishnok, J.S., Tannenbaum, S.R. and Sinha, R. (1997) Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans: relationship to cytochrome P4501A2 and N-acetyltransferase activity. Cancer Res., 57, 3457-3464.